Skip to content

Assessing the Impact of Unnecessary Antibiotic Treatment on the Development of Appropriate Adaptive Immune Responses in Malnourished Bangladeshi Infants

Assessing the Impact of Unnecessary Antibiotic Treatment on the Development of Appropriate Adaptive Immune Responses in Malnourished Bangladeshi Infants

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07615842
Enrollment
150
Registered
2026-05-29
Start date
2026-06-01
Completion date
2028-06-01
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Resistance Prevention

Brief summary

The investigators are examining the role of circulating T follicular helper (Tfh) cells in the induction of the antibody responses. The investigators hypothesize that Tfh cell activation is impaired in Bangladeshi children and that this activation failure is associated with a history of antibiotic use. The results of the investigators' preliminary studies suggest that antibiotic treatment could have a detrimental effect on the development of an appropriate adaptive immune response against Cryptosporidium. Antibiotic treatment for children with cryptosporidiosis, rotavirus and adenovirus 40/41is not currently recommended (supportive therapy only), although usually given to children in Dhaka, Bangladesh. This study will randomly assign children with diarrhea due to Cryptosporidium, rotavirus or adenovirus 40/41 to two groups. Supportive treatment would be provided in both groups, but in group #1, antibiotic treatment would be withheld while group #2 will receive usual care which normally will include antibiotic treatment. The investigators will monitor the children for one year to measure T follicular helper function, antibody production, and reinfection.

Interventions

DRUGAzithromycin

Antibiotic treatment (azithroymicin) for children with cryptosporidiosis is not currently recommended (supportive therapy only). The proposed modification to this study would involve randomly assigning the Cryptosporidium-positive children to two groups. Supportive treatment would be provided in both groups, but in one group, antibiotic treatment would be withheld. All children would continue to be monitored in accordance with standard protocols, and antibiotic treatment would be provided if deemed clinically necessary.

Sponsors

University of Virginia
Lead SponsorOTHER
International Centre for Diarrhoeal Disease Research, Bangladesh
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
6 Months to 48 Months
Healthy volunteers
No

Inclusion criteria

* presenting with diarrheal symptoms * age under 1 year * enrolled in study NCT02764918

Exclusion criteria

* unwilling to give blood and stool samples

Design outcomes

Primary

MeasureTime frame
T follicular helper activation1 year

Secondary

MeasureTime frameDescription
Antibodies to pathogens1 yearAntibodies to cryptosporidium, rotavirus and/or adenovirus 40/41
Reinfection1 yearReinfection with cryptosporidium, rotavirus and/or adenovirus 40/41
Measures of Malnutrition1 yearWeight, height

Countries

Bangladesh

Contacts

CONTACTMary Young
mky4n@virginia.edu4348061737

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026